Immunogenicity and Safety of the AS01E-adjuvanted Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine in Adults Aged 18-49 Years at Increased Risk of RSV Disease Compared with Adults Aged >/=60 Years. (academic.oup.com)

Authors: Mitha E … Hulstrom V Journal: Clinical Infectious Diseases Published: 2026-05-20 DOI: https://doi.org/10.1093/cid/ciag058